Incidence and risk factors for major bleeding among patients undergoing percutaneous coronary intervention: Findings from the Norwegian Coronary Stent Trial (NORSTENT).
Per-Jostein SamuelsenAnne Elise EggenTerje SteigenTom WilsgaardAndreas KristensenAnne SkogsholmElizabeth HolmeChristian van den HeuvelJan Erik NordrehaugBjørn BendzDennis W T NilsenKaare Harald BønaaPublished in: PloS one (2021)
Unique identifier NCT00811772; http://www.clinicaltrial.gov.
Keyphrases
- percutaneous coronary intervention
- coronary artery disease
- patients undergoing
- st segment elevation myocardial infarction
- atrial fibrillation
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- phase iii
- antiplatelet therapy
- coronary artery
- acute coronary syndrome
- study protocol
- phase ii
- clinical trial
- randomized controlled trial
- open label
- heart failure
- left ventricular
- placebo controlled
- aortic valve